CME Group Inc.
CME · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -2.35 | 3.58 | 2.60 | -5.44 |
| FCF Yield | 0.98% | 1.05% | 1.16% | 1.19% |
| EV / EBITDA | 75.29 | 68.99 | 71.16 | 68.81 |
| Quality | ||||
| ROIC | 2.00% | 2.34% | 2.34% | 2.11% |
| Gross Margin | 84.55% | 86.90% | 87.41% | 85.52% |
| Cash Conversion Ratio | 1.07 | 1.03 | 1.17 | 1.16 |
| Growth | ||||
| Revenue 3-Year CAGR | 6.16% | 7.16% | 7.11% | 6.89% |
| Free Cash Flow Growth | -8.69% | -5.65% | 11.16% | 1.90% |
| Safety | ||||
| Net Debt / EBITDA | 0.74 | 0.99 | 1.47 | 0.44 |
| Interest Coverage | 22.10 | 25.67 | 26.57 | 23.27 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 9.26 | -1.98 | -1.42 | 1.25 |